Stoke Therapeutics Inc (NASDAQ:STOK)

11.71
Delayed Data
As of Jun 09
 -0.98 / -7.72%
Today’s Change
6.88
Today|||52-Week Range
22.87
+26.87%
Year-to-Date
No recent news for Stoke Therapeutics Inc.

Today’s Trading

Previous close12.69
Today’s open12.55
Day’s range11.68 - 12.55
Volume8,616
Average volume (3 months)272,865
Market cap$525.4M
Data as of 3:59pm ET, 06/09/2023

Growth & Valuation

Earnings growth (last year)-11.25%
Earnings growth (this year)+4.59%
Earnings growth (next 5 years)-1.02%
Revenue growth (last year)--
P/E ratioNM
Price/Sales28.94
Price/Book2.60

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...+0.04+0.74%
AUTLAutolus Therapeutics...-0.05-1.71%
ANABAnaptysBio Inc+0.42+2.29%
ALPNAlpine Immune Scienc...-0.13-1.25%
Data as of 3:59pm ET, 06/09/2023

Financials

Next reporting dateAugust 15, 2023
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$12.4M
Annual profit (last year)-$101.1M
Net profit margin-814.73%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Bedford, Massachusetts

Forecasts